The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

For example, the FDA said about 20% of the bioreactor ... Sanofi (NYSE: SNY) acquired the Framingham facility when it bought Massachusetts-based Genzyme in a deal worth over $20 billion in 2011.

The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...

Elshoma McCoy, 49, of 176 Waverly St., Framingham, is charged with illegal possession of a firearm; illegal possession of a ...

A 49-year-old man from Framingham was arrested following an investigation that led to the recovery of a firearm and drugs at ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...

Framingham Police arrested a 49-year-old man, seizing drugs and a ghost gun. He's held on $2 million bail awaiting trial.

The Food and Drug Administration has proposed moving nutrition labels to the front of most packaged foods, aiming to help consumers make healthier choices, officials said. The FDA officially unveiled ...

The U.S. Food and Drug Administration has warned the ... ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi ...